Raymond James Financial
MIRM icon

Raymond James Financial’s Mirum Pharmaceuticals MIRM Stock Holding History

Raymond James Financial’s Portfolio MIRM Stock Details MIRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21.1M Sell
228,174
-18,244
-7% -$1.72M 0.01% 1434
2025
Q4 		$19.5M Sell
246,418
-5,315
-2% -$381K 0.01% 1457
2025
Q3 		$18.5M Sell
251,733
-12,385
-5% -$787K 0.01% 1468
2025
Q2 		$13.4M Buy
264,118
+14,800
+6% +$659K ﹤0.01% 1651
2025
Q1 		$11.2M Sell
249,318
-7,294
-3% -$344K ﹤0.01% 1719
2024
Q4 		$10.6M Buy
+256,612
New +$10.7M ﹤0.01% 1801

Other funds holding MIRM

FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Raymond James Financial's MIRM Position: Q1 2026 in Review

Raymond James Financial reduced its Mirum Pharmaceuticals (MIRM) stake by 7.4% in Q1 2026, selling an estimated $1.72M and leaving 228,174 shares worth $21.1M. The position accounts for 0.01% of the portfolio, ranked #1434.

Raymond James Financial first reported a position in MIRM in Q4 2024 and has held it in 6 quarters since. 311 funds tracked by Wall St. Rank hold MIRM as of Q1 2026.

  • Raymond James Financial held 228,174 shares of Mirum Pharmaceuticals worth $21.1M as of Q1 2026.
  • Raymond James Financial sold 18,244 Mirum Pharmaceuticals shares in Q1 2026, an estimated $1.72M.
  • Mirum Pharmaceuticals made up 0.01% of Raymond James Financial's portfolio in Q1 2026, its #1434 holding.
  • Raymond James Financial first reported a position in Mirum Pharmaceuticals in Q4 2024 and has held it in 6 quarters since.
  • 311 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.